Navigation Links
Disabling gene defuses rheumatoid arthritis in mice

Scientists studying mice have identified a gene that allows immune cells known as neutrophils to protect themselves from the inflammatory chemicals they secrete.

Researchers at Washington University School of Medicine in St. Louis showed that knocking the gene out in mice prevented the development of an arthritis-like disorder by making the neutrophils victims of their own damaging secretions.

The newly identified role for the gene, Foxo3a, may open a new window for treating arthritic conditions caused by immune dysfunction. Currently, most treatments in development for these disorders focus either on preventing wayward immune cells from attacking the joints or on reducing the ability of these cells to open fire. The new results suggest it may be just as helpful to let these cells kill themselves and each other.

"We already know a great deal about Foxo3a from studies of its role in some cancers, and hopefully that puts us in a good position to devise ways to manipulate its activity," says senior author Stanford Peng, M.D., Ph.D., assistant professor of medicine and of pathology and immunology. "If the human version of this gene functions in a similar fashion, modifying its activity may be a useful approach for arthritis therapy even when the disease is already well underway."

Peng and colleagues will publish their results in the June issue of Nature Medicine.

Rheumatoid arthritis, the most prevalent autoimmune form of arthritis, afflicts approximately 2.1 million Americans or about 1 percent of the population. Women are two to three times more likely to develop the disorder than men. Symptoms often occur in episodic bursts and may include morning stiffness, fatigue and joint and muscle pain. In severe cases, rheumatoid arthritis can damage cartilage, tendons, ligaments and bone, leading to joint deformity and instability.

Rheumatoid arthritis has long been recognized as a condition that involves defensive cells from the body's immune system mistakenly attacking healthy joint tissues. Scientists once thought the cells that were most active in these attacks were adaptive immune cells including T cells. Most of these cells are like guided missiles: they get a fix on a specific target, pursue it and attack it.

"Classically, everyone thought that the T cells somehow recognized something specific in the joint like collagen or some other protein and attacked it," Peng explains. "In recent years, though, it's become more accepted that rheumatoid arthritis is also the result of a less specific but still harmful inflammation generated by cells from the other branch of the immune system, the innate immune system."

Innate immune cells such as neutrophils respond rapidly to invaders and normally comprise the body's frontline defenses against bacterial infection.

Peng became interested in Foxo3a because of prior studies his research team had conducted on a related gene, Foxj1. Both genes belong to the forkhead family of genes, which regulates the activity of other genes and has been connected to cancer and longevity. Last year Peng found that knocking out Foxj1 produced a lupus-like condition in mice.

Foxj1 and Foxo3a are thought to play similar roles in immune T cells. To get a better sense for Foxo3a's activities, Peng's group created a line of mice where Foxo3a had been disabled and studied the effects this change had on T cells.

As a follow-up, Peng decided to inject the new line of mice with antibodies that normally induce a condition like rheumatoid arthritis. But the mice remained healthy even after the injections.

"It was a surprise finding," Peng says. "We really didn't expect to see this kind of response."

Further study revealed that neutrophils in the mice were killing themselves through a cellular self-destruct process known as apoptosis. Damaged or highly stressed cells can pull their own plug in this or a similar manner to pr event themselves from becoming cancerous.

"It seems that evolution has somehow provided protective mechanisms for innate immune cells when they go into the hazardous inflammatory environments they create," Peng notes. "They need ways to keep themselves alive, and Foxo3a is one of those ways."

Peng's group is currently trying to discern more details of Foxo3a's activities in neutrophils, including the pathways the gene activates to block apoptosis. They will also be looking for drugs that inhibit Foxo3a and testing them in the mice as potential anti-arthritis drugs.

###

Jonsson H, Allen P, Peng SL. "Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis." Nature Medicine, June 2005.


'"/>

Source:Washington University School of Medicine


Related biology news :

1. New genes implicated in rheumatoid arthritis
2. Enzymes newly discovered role may make it target for arthritis treatment
3. Results of worlds first gene therapy trial for arthritis show approach safe, feasible
4. Science finds new fix for UV-damaged skin in arthritis treatment
5. Matrilin-3 gene discovered to prevent onset of osteoarthritis
6. New engineered drug may offer prolonged arthritis relief
7. Osteoarthritis may be sign of faster biological ageing
8. Cartilage discovery offers arthritis hope
9. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
10. Novel antiviral technology inhibits RSV infection in mice
11. Signaling protein builds bigger, better bones in mice
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/15/2016)... 2016   WaferGen Bio-systems, Inc. (NASDAQ: ... announced today that on December 13, 2016, it received ... Nasdaq Stock Market LLC which acknowledged that, as of ... common stock had been at $1.00 or greater for ... with Listing Rule 5550(a)(2) of the Nasdaq Stock Market. ...
(Date:12/12/2016)... , Dec. 12, 2016  Researchers at Trinity ... for graphene by combining the material with Silly ... sensitive pressure detector able to sense pulse, blood ... small spider.  The research team,s ... be read here:  http://science.sciencemag.org/content/354/6317/1257 ...
(Date:12/7/2016)... Avanade is helping Williams Martini Racing, one of ... biometric data in order to critically analyse every aspect ... against their rivals after their impressive, record-breaking pit stop ... with Williams during the 2016 season to capture and ... rate, temperature and peak acceleration) for key members of ...
Breaking Biology News(10 mins):
(Date:1/16/2017)... ... 2017 , ... Attagene , a Research Triangle Park-based ... Business Administration. The Tibbetts Award honors the Small Business Innovation Research (SBIR) ... considered the best of the best from the thousands of firms that currently ...
(Date:1/14/2017)... ... January 14, 2017 , ... Seattle-based Phase Genomics ... genome assemblies to researchers around the globe. Long considered a “holy grail” ... a wide range of scientific questions. The announcement was made today at ...
(Date:1/13/2017)... 13, 2017 Research and Markets has announced ... - Global Forecast to 2021" report to their offering. ... The biosimilars market ... 3.39 Billion in 2016, at a CAGR of 26.3%. ... product, manufacturing type, and application. Factors such as rising incidence of ...
(Date:1/13/2017)... Kalamazoo, Michigan (PRWEB) , ... January 13, 2017 ... ... manufacture and market products containing an organic compound called fulvic acid that farms, ... , Hydroponics operations that grow cannabis are among the fastest growing segments of ...
Breaking Biology Technology: